Hysteroscopic Endometrial Resection Market
Number of pages: 100 | Report Format: PDF | Published date: May 30, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 244.80 million |
|
Revenue Forecast in 2031 |
US$ 392.23 million |
|
CAGR |
5% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Instrument type, End user, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global hysteroscopic endometrial resection market was valued at US$ 244.80 million in 2022 and is expected to register a revenue CAGR of 5% to reach US$ 392.23 million by 2031.
Hysteroscopic Endometrial Resection Market Fundamentals
Hysteroscopic endometrial resection (HER) is a surgical procedure in which the inner lining of the uterus, known as the endometrium, is removed or ablated using a hysteroscope. A hysteroscope is a thin, lighted tube that is inserted through the vagina and cervix into the uterus, allowing the surgeon to visualize and access the uterine cavity. During the procedure, specialized instruments are used to remove or destroy the endometrial tissue. The goal of hysteroscopic endometrial resection is to treat various gynecological conditions that affect the endometrium, such as abnormal uterine bleeding, endometrial hyperplasia, uterine septum, or Asherman's syndrome. Hysteroscopic endometrial resection is considered a minimally invasive procedure because it does not require any external incisions. It is typically performed as an outpatient, meaning the patient can go home on the same day. Compared to traditional open surgery, hysteroscopic endometrial resection offers advantages such as shorter recovery time, less pain, and reduced scarring.
Hysteroscopic Endometrial Resection Market Dynamics
The growing incidence of gynecological conditions such as abnormal uterine bleeding, endometrial hyperplasia, uterine polyps, and Asherman's syndrome in women is a key driver for the hysteroscopic endometrial resection market. As awareness and diagnostic advancements progress, there is a rising demand for hysteroscopic endometrial resection as a sought-after treatment choice due to its effectiveness. According to the National Center for Biotechnology Information, up to one-third of all women will experience abnormal uterine bleeding at some point in their lives, with irregularities most common during menarche and perimenopause. The global prevalence of abnormal uterine bleeding among reproductive-aged women is believed to be between 3% and 30%. Hysteroscopic endometrial resection is a minimally invasive procedure that offers advantages over traditional open surgery. It involves smaller incisions, reduced postoperative pain, shorter hospital stays, faster recovery, and minimal scarring. Patients' and healthcare providers’ growing preference for less invasive procedures drives the adoption of hysteroscopic endometrial resection. Advancements in hysteroscopic instruments and equipment, such as high-definition imaging systems, smaller hysteroscopes, and improved surgical tools, have enhanced the precision and effectiveness of hysteroscopic endometrial resection procedures. These hysteroscopic endometrial resection industry trends continue to drive market growth as advanced technology enables better visualization, increased safety, and improved surgical outcomes. There is a greater emphasis on women's health and well-being in healthcare systems worldwide. This increased focus has led to improved access to diagnostic procedures and treatment options for gynecological conditions, including hysteroscopic endometrial resection. Hysteroscopic endometrial resection is typically performed as an outpatient, allowing patients to go home on the same day of the procedure. This aligns with the increasing trend towards outpatient care, as it reduces healthcare costs, improves patient convenience, and minimizes the need for hospitalization, propelling the hysteroscopic endometrial resection market growth.
However, while generally regarded as safe, the hysteroscopic endometrial resection procedure is not without risks and potential complications. These include the possibility of uterine perforation, bleeding, infection, anesthesia-related issues, and unintended damage to nearby structures, which restricts the hysteroscopic endometrial resection market demand. Depending on the specific gynecological condition and patient characteristics, alternative treatment options exist for managing endometrial disorders. These alternatives, such as hormonal therapy, oral medications, or other minimally invasive procedures, are preferred in certain cases, which is also hampering the growth of the hysteroscopic endometrial resection market.
Hysteroscopic Endometrial Resection Market Ecosystem
The global hysteroscopic endometrial resection market is analyzed from three perspectives: instrument type, end user, and region.
Hysteroscopic Endometrial Resection Market by Instrument Type
Based on the instrument types, the global hysteroscopic endometrial resection market is segmented into assembled operative hysteroscopes, semi-rigid hysteroscopic scissors, continuous-flow operative hysteroscopes, operative hysteroscopes, and accessories.
The hysteroscopes segment accounted for the largest revenue share of the hysteroscopic endometrial resection market in 2022. Hysteroscopes are the primary instruments used in hysteroscopic endometrial resection procedures. These devices consist of a thin, lighted tube that allows visualization of the uterine cavity and facilitates the surgical removal or ablation of the endometrial tissue. Hysteroscopes are crucial for accurate diagnosis, precise tissue removal, and overall procedural success. Hysteroscopes have undergone significant technological advancements in recent years. High-definition imaging systems, smaller and more flexible scopes, and improved optical capabilities have enhanced visualization and precision during hysteroscopic endometrial resection procedures. These technological advancements contribute to better surgical outcomes and increased demand for hysteroscopes. Hysteroscopes have many applications beyond hysteroscopic endometrial resection, including diagnostic hysteroscopy and other therapeutic procedures. They can be used to evaluate and treat various gynecological conditions, such as uterine polyps, fibroids, and intrauterine adhesions. The versatility and multiple applications of hysteroscopes make them indispensable in gynecological surgeries, including hysteroscopic endometrial resection. According to the National Center for Biotechnology Information, the estimated incidence of uterine fibroids ranges between 20 and 77%, with a frequency of 40-60% among women under the age of 35 and 70-80% among women over the age of 50. The hysteroscopes segment of the hysteroscopic endometrial resection market has witnessed intense competition among manufacturers. This competition has driven continuous product innovations, improved functionalities, and cost-effectiveness. The focus on developing advanced hysteroscopes with superior imaging capabilities and user-friendly features further contributes to the growth of this segment.
The semi-rigid hysteroscopic scissors segment accounted for a considerable hysteroscopic endometrial resection market share in 2022. Semi-rigid hysteroscopic scissors offer versatility in performing tissue resection during hysteroscopic endometrial resection procedures. These scissors are specifically designed for precise cutting and resection of endometrial tissue, uterine polyps, or other abnormal growths. Their semi-rigid nature allows for effective manipulation and tissue removal in the uterine cavity. Semi-rigid hysteroscopic scissors enable surgeons to perform precise and controlled tissue resection, effectively removing the targeted pathology. These scissors' sharp and precise cutting edge allows for efficient tissue removal while minimizing the risk of damage to surrounding structures. The design of semi-rigid hysteroscopic scissors often incorporates features that enhance visibility during the procedure. This includes adjustable angles, illuminated tips, and ergonomic handles that provide better maneuverability and visualization of the surgical site, thus fueling segmental growth.
Hysteroscopic Endometrial Resection Market by End User
Based on the end users, the global hysteroscopic endometrial resection market is segmented into hospitals, ambulatory care centers, and others.
The hospital segment dominates the hysteroscopic endometrial resection market with the highest revenue share. Hospitals typically have advanced healthcare infrastructure and resources that facilitate the performance of hysteroscopic endometrial resection procedures. They have dedicated operating rooms equipped with state-of-the-art hysteroscopic equipment, surgical instruments, anesthesia support, and postoperative care facilities. This enables hospitals to provide comprehensive and specialized care for patients undergoing hysteroscopic endometrial resection. Hospitals generally have a skilled workforce, including gynecologists, surgeons, anesthesiologists, and nursing staff, who are trained in performing hysteroscopic endometrial resection procedures. Hospitals offer various healthcare services, including diagnostic imaging, pathology laboratories, and support from various medical specialties. This comprehensive approach allows for accurate diagnosis, preoperative evaluation, and coordinated multidisciplinary care for patients requiring hysteroscopic endometrial resection. Hospitals typically have established relationships with insurance providers and can navigate reimbursement processes more effectively. This ensures adequate reimbursement for hysteroscopic endometrial resection procedures and facilitates access to the necessary resources and equipment. The favorable reimbursement and insurance coverage policies associated with hospital settings make them the preferred choice for patients and healthcare providers. Many hospitals are affiliated with research and academic institutions, allowing them to stay at the forefront of medical advancements and innovative techniques. These institutions often conduct research, clinical trials, and educational programs related to gynecological surgeries, including hysteroscopic endometrial resection.
Hysteroscopic Endometrial Resection Market by Region
Geographically, the global hysteroscopic endometrial resection market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The North America region has the largest hysteroscopic endometrial resection market size in terms of revenue generation accounting for around 39.3% share of the market. North America has a significant prevalence of gynecological conditions such as abnormal uterine bleeding, endometrial hyperplasia, uterine polyps, and endometriosis. The rising incidence of these conditions among the population fuels the demand for hysteroscopic endometrial resection as an effective treatment option, driving market growth in the region. According to the Office on Women's Health (OASH), endometriosis affects around 11% of women in the U.S. between 15 and 44. North America is at the forefront of technological advancements in the healthcare industry, including hysteroscopic equipment and surgical techniques. The region witnessed the early adoption of innovative hysteroscopic endometrial resection technologies and instruments, improving procedural outcomes, patient satisfaction, and increased demand for hysteroscopic endometrial resection procedures. North America boasts a well-developed healthcare infrastructure with advanced hospitals, clinics, and ambulatory surgical centers. These facilities have state-of-the-art hysteroscopic equipment, advanced imaging systems, and a skilled workforce, providing a conducive environment for performing hysteroscopic endometrial resection procedures. North America has relatively favorable reimbursement policies for hysteroscopic procedures, including hysteroscopic endometrial resection. Insurance coverage and reimbursement support for hysteroscopic endometrial resection contribute to the accessibility and affordability of the procedure for patients. This favorable reimbursement environment encourages healthcare providers to offer hysteroscopic endometrial resection as a treatment option, driving the market growth.
Hysteroscopic Endometrial Resection Market Competitive Landscape
The prominent players operating in the global hysteroscopic endometrial resectionmarket are:
Hysteroscopic Endometrial Resection Market Strategic Developments
Hysteroscopic endometrial resection is a surgical procedure in which the inner lining of the uterus, known as the endometrium, is removed or ablated using a hysteroscope. A hysteroscope is a thin, lighted tube that is inserted through the vagina and cervix into the uterus, allowing the surgeon to visualize and access the uterine cavity.
Market players continuously invest in research and development to introduce new and advanced hysteroscopic endometrial resection products. They focus on enhancing the performance, functionality, and safety of hysteroscopic instruments, surgical tools, and associated equipment.
The prominent players operating in the global hysteroscopic endometrial resection market are Stryker Corporation, Karl Storz SE & Co., KG, Olympus Corporation, Richard Wolf GmbH, and WISAP Medical Technology GmbH.
The global hysteroscopic endometrial resection market growth is estimated to grow at a revenue CAGR of 5% during the forecast period from 2023 to 2031.
The estimated size of the global hysteroscopic endometrial resection market in 2031 is US$ 392.23 million.
*Insights on financial performance are subject to the availability of information in the public domain